This publication has been discontinued on September 9, 2011.
Abstract
Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming
Products and Technologies
Summary
While the leading cardiovascular device manufacturers continue to be impacted
by economic and regulatory challenges, factors such as increasing Research and
Development (R&D) costs, a shortening product pipeline and increasing
competition from small and medium-sized companies are putting additional
pressure on these manufacturers to stay competitive and remain profitable.
Considering the ever-expanding competitive landscape, it is important to have
a thorough analysis and intelligent insight on the key cardiovascular pipeline
devices expected to bring in dynamism in the market.
GlobalData’s new report, “Global Cardiovascular Devices Pipeline
Landscape: Analysis of Key Upcoming Products and Technologies” provides
key data, information and analysis on the key cardiovascular pipeline devices
expected to hit the market in the next seven years. Cardiovascular devices
remain a key segment within the medical equipment industry. This medical
device report also provides information on the market potential, market scope
and expected market penetration of these products. It also identifies and
reviews the existing competing technologies and the likely impact of the
launch on the competitive landscape.
This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by
GlobalData’s team of industry experts.
Scope
- Annualized market revenues data from 2000 to 2009, forecast forward for
seven years to 2016.
- The report profiles each pipeline product with
information on product description, features, benefits and advantages.
-
Pipeline product and market size information for the following categories -
Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular
Devices, Electrophysiology, Cardiovascular Prosthetic Devices, Cardiovascular
Surgery, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular
Devices
- The report analyses the safety and efficacy profile of each
product vis-à-vis other competing products already in market.
- The
report covers information on product details, indication details and clinical
trial status with projections on the market potential.
- The report also
reviews and analyses the trends shaping and defining the markets that the
products are being targeted in.
- Key topics covered in the report include
the device-specific developments, M&A landscape and strategic partnerships
expected to influence the launch and market penetration.
- Key players
covered include Medtronic, Cordis Corporation, St. Jude Medical, Boston
Scientific Corporation and Abbott.
Reasons to buy
- Develop business strategies by understanding the trends and developments
that are driving the cardiovascular devices pipeline and technology landscape
globally.
- Design and develop your product development, marketing and
sales strategies.
- Exploit M&A opportunities by identifying market
players with the most innovative pipeline.
- Develop market-entry and
market expansion strategies.
- Exploit in-licensing and out-licensing
opportunities by identifying products, most likely to ensure a robust
return.
- What’s the next being thing in the cardiovascular devices
technology landscape? - Identify, understand and capitalize.
-
Identify emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
- Stay ahead
of competition by understanding the changing competitive landscape in specific
geographies.
Table of Contents
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2
List of Figures 6
2 Global Cardiovascular Devices Market Overview 7
2.1 Cardiovascular Devices, Global, Revenue ($m), Historic, 2000-2009 7
2.2 Cardiovascular Devices, Global, Revenue ($m), Forecast, 2009-2016 8
2.3 Global Cardiovascular Devices Market: Company Shares 9
3 Cardiac
Rhythm Management : Pipeline Landscape 11
3.1 Cardiac Rhythm Management:
Market Overview 11
3.1.1 Cardiac Rhythm Management, Global, Revenue ($m),
Historic, 2000-2009 11
3.1.2 Cardiac Rhythm Management, Global, Revenue
($m), Forecast, 2009-2016 12
3.2 Cardiac Rhythm Management: Market
Dynamics 13
3.2.1 Market Drivers 13
3.2.2 Market Restraints 13
3.3
Cardiac Rhythm Management: Technology Landscape 14
3.3.1 MRI Compatible
Cardiac Rhythm Management Devices 14
3.3.2 EnRhythm MRI SureScan Pacing
System 14
3.3.3 Wireless Cardiac Stimulation Device 18
3.3.4 Paradym
sonR CRT- D 19
3.4 Cardiac Rhythm Management Pipeline Product Summary
22
4 Cardiovascular Monitoring and Diagnostic Devices: Pipeline Landscape
24
4.1 Cardiovascular Monitoring and Diagnostic Devices: Market Overview
24
4.1.1 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue
($ m), Historic,
2000-2009 24
4.1.2 Cardiovascular Monitoring and
Diagnostic Devices, Global, Revenue ($ m), Forecast, 2009-2016 25
4.2
Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics 26
4.2.1
Market Drivers 26
4.3 Cardiovascular Monitoring and Diagnostic Devices:
Technology Landscape 26
4.3.1 Leadless Cardiac Monitoring Device 26
4.4 Cardiovascular Monitoring and Diagnostic Devices Pipeline Product Summary
28
5 Cardiovascular Prosthetic Devices: Pipeline Landscape 31
5.1
Cardiovascular Prosthetic Devices: Market Overview 31
5.1.1 Cardiovascular
Prosthetic Devices, Global, Revenue ($ m), Historic, 2000-2009 31
5.1.2
Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Forecast, 2009-2016
32
5.2 Cardiovascular Prosthetic Devices: Market Dynamics 33
5.2.1
Market Drivers 33
5.2.2 Market Restraints 34
5.3 Cardiovascular
Prosthetic Devices: Technology Landscape 34
5.3.1 AbioCor II 34
5.3.2
3f Enable Aortic Valve 36
5.3.3 Perceval S Sutureless Aortic Valve 38
5.3.4 SAPIEN Transcatheter Heart Valve 40
5.3.5 Melody Transcatheter
Pulmonary Valve 43
5.4 Cardiovascular Prosthetic Devices Pipeline Product
Summary 48
6 Cardiovascular Surgery: Pipeline Landscape 53
6.1
Cardiovascular Surgery: Market Overview 53
6.1.1 Cardiovascular Surgery,
Global, Revenue ($ m), Historic, 2000-2009 53
6.1.2 Cardiovascular
Surgery, Global, Revenue ($ m), Forecast, 2009-2016 54
6.2 Cardiovascular
Surgery: Market Dynamics 55
6.2.1 Market Drivers 55
6.2.2 Market
Restraints 55
6.3 Cardiovascular Surgery: Technology Landscape 56
6.3.1 CyberHeart System 56
6.4 Cardiovascular Surgery Pipeline Product
Summary 57
7 Electrophysiology: Pipeline Landscape 59
7.1
Electrophysiology: Market Overview 59
7.1.1 Electrophysiology, Global,
Revenue ($ m), Historic, 2000-2009 59
7.1.2 Electrophysiology, Global,
Revenue ($ m), Forecast, 2009-2016 60
7.2 Electrophysiology: Market
Dynamics 61
7.2.1 Market Drivers 61
7.2.2 Market Restraints 61
7.3
Electrophysiology: Technology Landscape 61
7.3.1 Sensei System for Atrial
Fibrillation 61
7.4 Electrophysiology Pipeline Product Summary 64
8
Interventional Cardiology: Pipeline Landscape 66
8.1 Interventional
Cardiology: Market Overview 66
8.1.1 Interventional Cardiology, Global,
Revenue ($ m), Historic, 2000-2009 66
8.1.2 Interventional Cardiology,
Global, Revenue ($ m), Forecast, 2009-2016 67
8.2 Interventional
Cardiology: Market Dynamics 68
8.2.1 Market Drivers 68
8.2.2 Market
Restraints 69
8.3 Interventional Cardiology: Technology Landscape 69
8.3.1 Bioabsorbable stents 69
8.3.2 VestaSync 72
8.3.3 Combo
Bio-engineered Sirolimus Eluting Stent 74
8.3.4 Intravascular Ultrasound
76
8.3.5 AMPLATZER PFO Occluder - Migraine 78
8.4 Interventional
Cardiology Pipeline Product Summary 81
9 Peripheral Vascular Devices:
Pipeline Landscape 91
9.1 Peripheral Vascular Devices: Market Overview
91
9.1.1 Peripheral Vascular Devices, Global, Revenue ($ m), Historic,
2000-2009 91
9.1.2 Peripheral Vascular Devices, Global, Revenue ($ m),
Forecast, 2009-2016 93
9.2 Peripheral Vascular Devices: Market Dynamics
94
9.2.1 Market Drivers 94
9.2.2 Market Restraints 94
9.3
Peripheral Vascular Devices: Technology Landscape 94
9.3.1 ZILVER PTX Drug
Eluting Peripheral Stent 94
9.4 Peripheral Vascular Devices Pipeline
Product Summary 97
10 Appendix 102
10.1 Abbreviations 102
10.2
Definitions 103
10.2.1 Cardiovascular Devices 103
10.2.2 Cardiac
Rhythm Management 103
10.2.3 Cardiovascular Monitoring and Diagnostic
Devices 104
10.2.4 Cardiovascular Prosthetic Device 104
10.2.5
Cardiovascular Surgery 105
10.2.6 Electrophysiology 106
10.2.7
Interventional Cardiology 106
10.2.8 Peripheral Vascular Devices 107
10.3 Research Methodology 108
10.4 Secondary Research 109
10.5 Primary
Research 109
10.6 Models 110
10.7 Forecasts 110
10.8 Expert Panels
110
10.9 GlobalData Consulting 110
10.10 Contact Us 111
10.11
Disclaimer 111
1.1 List of Tables
Table 1: Cardiovascular
Devices, Global, Revenue ($ m), 2000-2009 7
Table 2: Cardiovascular
Devices, Global, Revenue ($ m), 2009-2016 9
Table 3: Global Cardiovascular
Devices Market, Company Shares, Revenue ($ m), 2008 10
Table 4: Cardiac
Rhythm Management, Global, Revenue ($m), 2000-2009 11
Table 5: Cardiac
Rhythm Management, Global, Revenue ($m), 2009-2016 12
Table 6: Paradym
sonR CRT defibrillator, Europe, Revenue ($ m), 2009-2016 20
Table 7:
Global Cardiac Rhythm Management Pipeline Product Summary - I 22
Table 8:
Global Cardiac Rhythm Management Pipeline Product Summary - II 23
Table 9:
Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m),
2000-2009 24
Table 10: Cardiovascular Monitoring and Diagnostic Devices,
Global, Revenue ($ m), 2009-2016 25
Table 11: Global Cardiovascular
Monitoring And Diagnostic Devices Pipeline Product Summary - I 28
Table
12: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product
Summary - II 29
Table 13: Global Cardiovascular Monitoring And Diagnostic
Devices Pipeline Product Summary - III 30
Table 14: Cardiovascular
Prosthetic Devices, Global, Revenue ($ m), 2000-2009 31
Table 15:
Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016 32
Table 16: Global Cardiovascular Prosthetic Devices Pipeline Product Summary -
I 48
Table 17: Global Cardiovascular Prosthetic Devices Pipeline Product
Summary - II 49
Table 18: Global Cardiovascular Prosthetic Devices
Pipeline Product Summary - III 50
Table 19: Global Cardiovascular
Prosthetic Devices Pipeline Product Summary - IV 51
Table 20: Global
Cardiovascular Prosthetic Devices Pipeline Product Summary - V 52
Table
21: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009 53
Table 22:
Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016 54
Table 23:
Global Cardiovascular Surgery Pipeline Product Summary - I 57
Table 24:
Global Cardiovascular Surgery Pipeline Product Summary - II 58
Table 25:
Electrophysiology, Global, Revenue ($ m), 2000-2009 59
Table 26:
Electrophysiology, Global, Revenue ($ m), 2009-2016 60
Table 27: Global
Electrophysiology Pipeline Product Summary -I 64
Table 28: Global
Electrophysiology Pipeline Product Summary -II 65
Table 29: Interventional
Cardiology, Global, Revenue ($ m), 2000-2009 66
Table 30: Interventional
Cardiology, Global, Revenue ($ m), 2009-2016 67
Table 31: Global
Interventional Cardiology Pipeline Product Summary - I 81
Table 32: Global
Interventional Cardiology Pipeline Product Summary - II 82
Table 33:
Global Interventional Cardiology Pipeline Product Summary - III 83
Table
34: Global Interventional Cardiology Pipeline Product Summary - IV 84
Table 35: Global Interventional Cardiology Pipeline Product Summary - V 85
Table 36: Global Interventional Cardiology Pipeline Product Summary - VI
86
Table 37: Global Interventional Cardiology Pipeline Product Summary -
VII 87
Table 38: Global Interventional Cardiology Pipeline Product Summary
- VIII 88
Table 39: Global Interventional Cardiology Pipeline Product
Summary - IX 89
Table 40: Global Interventional Cardiology Pipeline
Product Summary - X 90
Table 41: Peripheral Vascular Devices, Global,
Revenue ($ m), 2000-2009 92
Table 42: Peripheral Vascular Devices, Global,
Revenue ($ m), 2009-2016 93
Table 43: Global Peripheral Vascular Devices
Pipeline Product Summary - I 97
Table 44: Global Peripheral Vascular
Devices Pipeline Product Summary - II 98
Table 45: Global Peripheral
Vascular Devices Pipeline Product Summary - III 99
Table 46: Global
Peripheral Vascular Devices Pipeline Product Summary - IV 100
Table 47:
Global Peripheral Vascular Devices Pipeline Product Summary - V 101
1.2 List of Figures
Figure 1: Cardiovascular Devices, Global, Revenue
($m), 2000-2009 7
Figure 2: Cardiovascular Devices, Global, Revenue ($m),
2009-2016 8
Figure 3: Global Cardiovascular Devices Market, Company Shares
(%), 2008 9
Figure 4: Cardiac Rhythm Management, Global, Revenue ($m),
2000-2009 11
Figure 5: Cardiac Rhythm Management, Global, Revenue ($m),
2009-2016 12
Figure 6: EnRhythm MRI SureScan pacing system: Features and
Benefit Analysis 16
Figure 7: Wireless Cardiac Stimulation Device:
Features and Benefit Analysis 18
Figure 8: Paradym sonR CRT-D: Features
and Benefit Analysis 20
Figure 9: Cardiovascular Monitoring and Diagnostic
Devices, Global, Revenue ($ m), 2000-2009 24
Figure 10: Cardiovascular
Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016 25
Figure 11: Leadless Cardiac Monitoring Device: Features and Benefit Analysis
27
Figure 12: Cardiovascular Prosthetic Devices, Global, Revenue ($ m),
2000-2009 31
Figure 13: Cardiovascular Prosthetic Devices , Global,
Revenue ($ m), 2009-2016 32
Figure 14: AbioCor II: Features and Benefit
Analysis 35
Figure 15: 3f Enable Aortic Valve: Features and Benefit
Analysis 37
Figure 16: Perceval S Sutureless Aortic Valve: Features and
Benefit Analysis 39
Figure 17: SAPIEN Transcatheter Heart Valve: Features
and Benefit Analysis 41
Figure 18: Melody Transcatheter Pulmonary Valve:
Features and Benefit Analysis 44
Figure 19: Cardiovascular Surgery,
Global, Revenue ($ m), 2000-2009 53
Figure 20: Cardiovascular Surgery,
Global, Revenue ($ m), 2009-2016 54
Figure 21: CyberHeart System: Features
and Benefit Analysis 56
Figure 22: Electrophysiology, Global, Revenue ($
m), 2000-2009 59
Figure 23: Electrophysiology, Global, Revenue ($ m),
2009-2016 60
Figure 24: Sensei System for Atrial Fibrillation: Features
and Benefit Analysis, 2010 62
Figure 25: Interventional Cardiology,
Global, Revenue ($ m), 2000-2009 66
Figure 26: Interventional Cardiology,
Global, Revenue ($ m), 2009-2016 67
Figure 27: Abbott Bioabsorbable
Everolimus Eluting Coronary Stent: Features and Benefit Analysis, 2010 70
Figure 28: VestaSync: Features and Benefit Analysis, 2010 73
Figure 29:
Combo Bio-engineered Sirolimus Eluting Stent: Features and Benefit Analysis,
2010 75
Figure 30: Comparison of Coronary Angiogram With Intra Vascular
Ultrasound Image, 2010 77
Figure 31: Intra Vascular Ultrasound: Features
and Benefit Analysis, 2010 78
Figure 32: AMPLATZER PFO Occluder-migraine:
Features and Benefit Analysis, 2010 79
Figure 33: Peripheral Vascular
Devices, Global, Revenue ($ m), 2000-2009 91
Figure 34: Peripheral
Vascular Devices, Global, Revenue ($ m), 2009-2016 93
Figure 35: ZILVER
PTX Drug Eluting Peripheral Stent: Features and Benefit Analysis, 2010 95
Figure 36: GlobalData Methodology 109
